GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Piotroski F-Score

PT Kimia Farma Tbk (ISX:KAEF) Piotroski F-Score : 3 (As of Apr. 02, 2025)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Kimia Farma Tbk has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for PT Kimia Farma Tbk's Piotroski F-Score or its related term are showing as below:

ISX:KAEF' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 3

During the past 13 years, the highest Piotroski F-Score of PT Kimia Farma Tbk was 7. The lowest was 2. And the median was 5.


PT Kimia Farma Tbk Piotroski F-Score Historical Data

The historical data trend for PT Kimia Farma Tbk's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Piotroski F-Score Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 6.00 4.00 5.00 3.00

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 3.00 3.00 3.00

Competitive Comparison of PT Kimia Farma Tbk's Piotroski F-Score

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's Piotroski F-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was -1308199.429 + -102733.39 + -124048.018 + -195052.487 = Rp-1,730,033 Mil.
Cash Flow from Operations was 695330.409 + 11373.021 + -55520.203 + -68770.049 = Rp582,413 Mil.
Revenue was 2249756.299 + 2535778.854 + 2677916.631 + 2650568.513 = Rp10,114,020 Mil.
Gross Profit was 283963.778 + 820837.061 + 758846.042 + 773933.181 = Rp2,637,580 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(20550673.36 + 17585297.583 + 17343272.196 + 17067208.218 + 16802347.355) / 5 = Rp17869759.7424 Mil.
Total Assets at the begining of this year (Sep23) was Rp20,550,673 Mil.
Long-Term Debt & Capital Lease Obligation was Rp2,385,694 Mil.
Total Current Assets was Rp5,251,502 Mil.
Total Current Liabilities was Rp7,769,738 Mil.
Net Income was -9533.83 + 386.494 + -22144.279 + -155606.592 = Rp-186,898 Mil.

Revenue was 2098975.113 + 2303673.177 + 2642765.206 + 2768838.367 = Rp9,814,252 Mil.
Gross Profit was 1253986.55 + 858582.103 + 970117.626 + 989187.314 = Rp4,071,874 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(18658376.659 + 19797322.545 + 20197161.839 + 20599661.157 + 20550673.36) / 5 = Rp19960639.112 Mil.
Total Assets at the begining of last year (Sep22) was Rp18,658,377 Mil.
Long-Term Debt & Capital Lease Obligation was Rp1,096,311 Mil.
Total Current Assets was Rp8,602,236 Mil.
Total Current Liabilities was Rp8,839,235 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Kimia Farma Tbk's current Net Income (TTM) was -1,730,033. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Kimia Farma Tbk's current Cash Flow from Operations (TTM) was 582,413. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=-1730033.324/20550673.36
=-0.08418378

ROA (Last Year)=Net Income/Total Assets (Sep22)
=-186898.207/18658376.659
=-0.01001685

PT Kimia Farma Tbk's return on assets of this year was -0.08418378. PT Kimia Farma Tbk's return on assets of last year was -0.01001685. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PT Kimia Farma Tbk's current Net Income (TTM) was -1,730,033. PT Kimia Farma Tbk's current Cash Flow from Operations (TTM) was 582,413. ==> 582,413 > -1,730,033 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=2385694.01/17869759.7424
=0.13350454

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=1096311.275/19960639.112
=0.05492366

PT Kimia Farma Tbk's gearing of this year was 0.13350454. PT Kimia Farma Tbk's gearing of last year was 0.05492366. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=5251502.36/7769737.991
=0.67589182

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=8602236.014/8839235.087
=0.97318783

PT Kimia Farma Tbk's current ratio of this year was 0.67589182. PT Kimia Farma Tbk's current ratio of last year was 0.97318783. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PT Kimia Farma Tbk's number of shares in issue this year was 5574.985. PT Kimia Farma Tbk's number of shares in issue last year was 5591.47. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2637580.062/10114020.297
=0.26078453

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4071873.593/9814251.863
=0.41489394

PT Kimia Farma Tbk's gross margin of this year was 0.26078453. PT Kimia Farma Tbk's gross margin of last year was 0.41489394. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=10114020.297/20550673.36
=0.49215031

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=9814251.863/18658376.659
=0.52599709

PT Kimia Farma Tbk's asset turnover of this year was 0.49215031. PT Kimia Farma Tbk's asset turnover of last year was 0.52599709. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+0+1+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Kimia Farma Tbk has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

PT Kimia Farma Tbk  (ISX:KAEF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PT Kimia Farma Tbk Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines